Related references
Note: Only part of the references are listed.Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
Ina Oehme et al.
CLINICAL CANCER RESEARCH (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Nagma Khan et al.
BIOCHEMICAL JOURNAL (2008)
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
W. Weichert et al.
BRITISH JOURNAL OF CANCER (2008)
The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis
Yi-Shan Lee et al.
CANCER RESEARCH (2008)
Isoform-selective histone deacetylase inhibitors
Anton V. Bieliauskas et al.
CHEMICAL SOCIETY REVIEWS (2008)
Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer:: Specific role of class I histone deacetylases in vitro and in vivo
Wilko Weichert et al.
CLINICAL CANCER RESEARCH (2008)
Ubiquitin Proteasome System Stress Underlies Synergistic Killing of Ovarian Cancer Cells by Bortezomib and a Novel HDAC6 Inhibitor
Martina Bazzaro et al.
CLINICAL CANCER RESEARCH (2008)
Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks
Sarah K. Knutson et al.
EMBO JOURNAL (2008)
Maintenance of cardiac energy by histone deacetylase 3 metabolism in mice
Rusty L. Montgomery et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Quantitative Analysis of Histone Deacetylase-1 Selective Histone Modifications by Differential Mass Spectrometry
Anita Y. H. Lee et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally
Yu Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control
Srividya Bhaskara et al.
MOLECULAR CELL (2008)
Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer:: a retrospective analysis
Wilko Weichert et al.
LANCET ONCOLOGY (2008)
A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
S. Balasubramanian et al.
LEUKEMIA (2008)
Cyclin-dependent kinases and cell-cycle transitions: does one fit all?
Helfrid Hochegger et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
Xiang-Jiao Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Transforming pathways unleashed by a HDAC2 mutation in human cancer
S. Ropero et al.
ONCOGENE (2008)
Pancreatitis and calcium signalling - Report of an international workshop
Robert Sutton et al.
PANCREAS (2008)
Class I histone deacetylase expression in the human cyclic endometrium and endometrial adenocarcinomas
Claudia A. Krusche et al.
HUMAN REPRODUCTION (2007)
Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice
Stephan Zimmermann et al.
CANCER RESEARCH (2007)
Histone deacetylase inhibitors: Overview and perspectives
Milos Dokmanovic et al.
MOLECULAR CANCER RESEARCH (2007)
Histone deacetylase inhibitors: molecular mechanisms of action
W. S. Xu et al.
ONCOGENE (2007)
Phase IIB multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma
Elise A. Olsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Histone deacetylase 1 gene expression and Sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide
Nino Keshelava et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility
Rusty L. Montgomery et al.
GENES & DEVELOPMENT (2007)
Role for histone deacetylase 1 in human tumor cell proliferation
Silvia Senese et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Histone deacetylase inhibitors induce premature sister chromatid separation and override the mitotic spindle assembly checkpoint
Laura Magnaghi-Jaulin et al.
CANCER RESEARCH (2007)
Histone deacetylase inhibitors in cancer treatment:: A review of the clinical toxicity and the modulation of gene expression in cancer cells
O. Bruserud et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2007)
Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma
Tatsuya Rikimaru et al.
ONCOLOGY (2007)
FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma
Bhupinder S. Mann et al.
ONCOLOGIST (2007)
Negative and positive regulation of gene expression by mouse histone deacetylase 1
Gordin Zupkovitz et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Inhibition of histone deacetylase class I but not class II is critical for the sensitization of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis
Satoshi Inoue et al.
CANCER RESEARCH (2006)
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition
S Ropero et al.
NATURE GENETICS (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast
ZH Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma
T Hideshima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1
BH Huang et al.
CELL DEATH AND DIFFERENTIATION (2005)
The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation
K Schmidt et al.
JOURNAL OF CELL BIOLOGY (2005)
Histone deacetylase-1 and-3 protein expression in human breast cancer:: a tissue microarray analysis
CA Krusche et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Mitotic spindle checkpoint inactivation by trichostatin A defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents
M Dowling et al.
CANCER BIOLOGY & THERAPY (2005)
Upregulation and nuclear recruitment of HDACI in hormone refractory prostate cancer
K Halkidou et al.
PROSTATE (2004)
Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis
IV Gregoretti et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate
K Halkidou et al.
EUROPEAN UROLOGY (2004)
Pathways of apoptotic and non-apoptotic death in tumour cells
H Okada et al.
NATURE REVIEWS CANCER (2004)
Histone deacetylase 1 mRNA expression in lung cancer
H Sasaki et al.
LUNG CANCER (2004)
HDAC6 expression is correlated with better survival in breast cancer
ZH Zhang et al.
CLINICAL CANCER RESEARCH (2004)
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
P Zhu et al.
CANCER CELL (2004)
Histone hyperacetylation in mitosis prevents sister chromatid separation and produces chromosome segregation defects
D Cimini et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression
G Lagger et al.
EMBO JOURNAL (2002)
Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: A tool for temporally regulated gene activation/inactivation in the mouse
S Hayashi et al.
DEVELOPMENTAL BIOLOGY (2002)
Expression profile of histone deacetylase 1 in gastric cancer tissues
JH Choi et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein
DS Sohal et al.
CIRCULATION RESEARCH (2001)
High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP
CI Rodríguez et al.
NATURE GENETICS (2000)
Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells
L Qiu et al.
MOLECULAR BIOLOGY OF THE CELL (2000)
Share Paper
